Selonsertib
- Generic Name
- Selonsertib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H24FN7O
- CAS Number
- 1448428-04-3
- Unique Ingredient Identifier
- NS3988A2TC
- Background
Selonsertib is under investigation in clinical trial NCT03053050 (Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis).
- Associated Conditions
- -
- Associated Therapies
- -
Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH)
- Conditions
- Interventions
- First Posted Date
- 2016-08-03
- Last Posted Date
- 2019-02-06
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 104
- Registration Number
- NCT02854631
- Locations
- ๐บ๐ธ
University of Washington, Seattle, Washington, United States
๐จ๐ฆToronto General Hospital, Toronto, Ontario, Canada
๐บ๐ธUniversity of Pennsylvania, Philadelphia, Pennsylvania, United States
Study to Evaluate the Pharmacokinetics of Selonsertib in Participants With Normal and Impaired Hepatic Function
- First Posted Date
- 2015-07-28
- Last Posted Date
- 2021-01-27
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 52
- Registration Number
- NCT02509624
Selonsertib in Adults With Pulmonary Arterial Hypertension
- Conditions
- Interventions
- First Posted Date
- 2014-09-09
- Last Posted Date
- 2019-04-10
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 151
- Registration Number
- NCT02234141
- Locations
- ๐บ๐ธ
VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
๐จ๐ฆUniversity Health Network, Toronto, Ontario, Canada
๐บ๐ธUniversity of Minnesota, Minneapolis, Minnesota, United States
Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease
- Conditions
- Interventions
- First Posted Date
- 2014-06-30
- Last Posted Date
- 2019-11-05
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 334
- Registration Number
- NCT02177786
- Locations
- ๐บ๐ธ
Northwest Louisiana Nephrology, Shreveport, Louisiana, United States
๐บ๐ธPines Clinical Research Inc., Pembroke Pines, Florida, United States
๐บ๐ธFlorida Pulmonary Research Institute, Winter Park, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.